Dear Travis, Thanks for your ongoing support and feedback. Our food safety test with the USDA detects the strain of E. coli implicated in the most recent Romaine lettuce incident. The plan is to make the test available to all 7,000 USDA testing laboratories as soon as possible. Thanks, Mark
Response to my Email regarding the e-coli incident recently. I asked him if they are working on it or planning on it with the food safety test.
Also,
Asked about the allergy test and if it’s available in AZ yet, which clinics have it available already.....
Dear Travis, We have allergy testing clinics in Phoenix, Gilbert, Anthem, Surprise, Tucson, Chandler, Safford, Snowflake, Scottsdale, Tempe, Flagstaff, Marana, Prescott and Lakeside. Which of these would be most convenient? Thanks, Mark
So...
(Currently generating revenue off allergy test)
Also this,
Dear Travis, Enclosed is the requested information. Thanks, Mark
On Nov 20, 2018, at 1:50 AM, Travis Comer <tcomer1717@gmail.com> wrote:
Hi Mark,
In regards to GE healthcare and BioPark information.
Me:
1.) Did you accept the invitation and attend the BioPark?
Mark:
Our current plan is to expand operations in California, with an eye on the BioPark going forward.
Me:
2.) Do you currently have an NDA with GE healthcare?
Mark:
Yes.
Me:
3.) Can you elaborate on the OEM with GE?
Mark:
For strategic reasons, the details are confidential.
GE -General Electric
NDA -(Non disclosure agreement)
OEM -(original engineering manufacturer)
So they are also working with GE Healthcare, Manufacturing something for GE Healthcare...
they could be about to announce a deal with Kaiser Permanente as well. Which is massive....
MOST RECENT PRESS RELEASE:
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health
Source: GlobeNewswire Inc.
Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health, one of the nation’s largest healthcare networks, is headquartered in Sacramento California and has 50,000 employees including 12,000 physicians and 14,000 nurses serving 3 million Northern California patients. Sutter Health draws 19% of its revenue from the California Medical Assistance Program (Medi-Cal) and reports total patient service revenues of $12,000,000,000 ($12 billion) annually.
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, signed allergy testing contracts with a consortium of 178 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS), reported the sale and shipping of clinical instrumentation to the FDA, aced three consecutive rounds of proficiency testing with the College of American Pathologists, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations and announced allergy test brands expansion. The agreement with Sutter Health significantly expands the company’s allergy testing bandwidth to include a major healthcare provider.
Chief Executive Officer Rene Schena states, “Partnering with healthcare leader Sutter Health fits perfectly within our mission of providing the most advanced allergy testing services available to our diverse Northern California healthcare community. Sutter’s focus on technological innovation, electronic medical records advances and telemedicine are highly synergistic with our physician-prescribed non-invasive finger stick microarray tests for allergy and other health and wellness indications.
Back to Kaiser....
Kaiser has over 12mil patients to date....
if 1/12 of them receive an allergy test”covered by insurance” that’s $400 a test
$400 X 1mil patients = $400,000,000 in revenue on one test with one customer....
80mil in revs with a 40mil earning gets a $4 share price..... Per Mark
Using that same ratio from Mark
That’s $200,000,000 in earnings.
If 40mil earnings gets $4 share price
200mil earnings gets $20 share price
That’s one test with one customer at a 1/12 projection......
Can’t we now start talking about other revenue streams..... LOL
If you don’t wanna talk Kaiser lets stay on sutter.... 3mil patients.
Same ratio
1/12 of patients is 250,000 patients.
250,000 X $400(a test) = $100,000,000
1/2 of that is $50,000,000 in earnings.
That’s a $5 share price with sutter at 1/12 of their patients receiving their one test.......
“mind currently exploding”
AI
